February 2019 - For ten years now, the International CML Foundation has been honouring people who have made outstanding contributions to our understanding of the biology of CML and to advance the management of CML.

There is now a long list of deserving awardees and we are very pleased to introduce you to the prize recipients in 2019:

• Rowley Prize - Professor Michael Deininger (USA). This award acknowledges outstanding contributions to the understanding of the biology of CML and is awarded to Michael Deininger in recognition of his involvement in researching the biology of CML that has contributed to the establishment of TKI-based therapies and significantly changed the way CML is diagnosed, monitored and treated today.

• Goldman Prize – Professor François-Xavier Mahon (France). This prize recognises outstanding contributions to the clinical management of CML and is awarded to François-Xavier Mahon for his pioneering work in leading the discussion on treatment-free remission and treatment discontinuation by providing solid scientific evidence through numerous pioneering studies.

• iCMLf Prize – Dr Carolina Pavlovsky (Argentina). The iCMLf prize recognises outstanding contributions to improving the treatment of CML in the emerging economic regions. Carolina Pavlovsky receives the prize for her efforts to continually bringing in the ‘real-world’ perspective into the scientific discussion of CML management and for her commitment to finding workable solutions for those areas with limited access to resources. 

From the many nominations submitted by the CML community, the three prize winners were selected by a panel of the iCMLf Advisors and Directors along with previous prize winners.

The 2019 prize medals will be awarded during award ceremonies at the annual John Goldman Conference on CML in Bordeaux (France) from September 12-15. During keynote presentations the award winners will provide insights into their work and research activities. We hope to see you in Bordeaux! Remember, the deadline for abstract submissions is May 8, 2019.

We congratulate all recipients on their prizes and thank them on behalf of the entire CML community for their outstanding commitment to improving the outcomes for patients with CML.